Mary‐Claire King
- Genetics top 0.01%
- BRCA gene mutations in cancer 97
- Genomic variations and chromosomal abnormalities 40
- Genetic Associations and Epidemiology 24
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 29
- Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment 20
- Sensory Systems top 0.1%
- Hearing, Cochlea, Tinnitus, Genetics 20
- Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer 24
-
- DNA Repair Mechanisms 43
- Co-authors
- Allan C. WilsonMing K. LeeTom WalshJessica B. MandellJoan H. MarksBeth NewmanJon McClellanK M Vranizan
- Partner nations
- United StatesIsraelPalestinian Territory
In The Last Decade
Mary‐Claire King
287 papers receiving 26.7k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Genetics 13.7k
- Cancer Research 4.7k
- Reproductive Medicine 2.5k
- Sensory Systems 1.4k
- Pathology and Forensic Medicine 3.4k
Countries citing papers authored by Mary‐Claire King
This map shows the geographic impact of Mary‐Claire King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Claire King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Claire King more than expected).
Fields of papers citing papers by Mary‐Claire King
This network shows the impact of papers produced by Mary‐Claire King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Claire King. The network helps show where Mary‐Claire King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary‐Claire King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 38 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 19 | |
| 9 | 2018 | 42 | |
| 10 | Dr. Segel and colleagues reply | 2014 | 50 |
| 11 | Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomasbreakdown → | 2013 | 712 |
| 12 | 2011 | 11 | |
| 13 | 2011 | 182 | |
| 14 | Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingbreakdown → | 2011 | 662 |
| 15 | Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2breakdown → | 2003 | 1625 |
| 16 | 2002 | 170 | |
| 17 | 2002 | 177 | |
| 18 | 1997 | 22 | |
| 19 | Genetic epidemiology of low density lipoprotein subclasses a common allele predisposing to coronary heart disease | 1986 | 4 |
| 20 | 1977 | 16 |
About Mary‐Claire King
Mary‐Claire King is a scholar working on Genetics, Sensory Systems and Reproductive Medicine, having authored 298 papers that have together received 27.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (97 papers), DNA Repair Mechanisms (43 papers), Genomic variations and chromosomal abnormalities (40 papers), Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (24 papers), Genetic Associations and Epidemiology (24 papers), Ovarian cancer diagnosis and treatment (20 papers) and Hearing, Cochlea, Tinnitus, Genetics (20 papers). The work is most often cited by research in Genetics (13.7k citations), Cancer Research (4.7k citations) and Reproductive Medicine (2.5k citations). Mary‐Claire King has collaborated with scholars based in United States, Israel and Palestinian Territory. Frequent co-authors include Allan C. Wilson, Ming K. Lee, Tom Walsh, Jessica B. Mandell, Joan H. Marks, Beth Newman, Jon McClellan, K M Vranizan, Jeff Hall and Lee Anderson. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.